glp-1 therapy for diabetes Beyond Blood Glucose: How GLP-1s are Changing Management GLP-1 Agonists For Obesity In

Two advanced injectable medications Mounjaro and Ozempic have shown significant benefits for both blood sugar control and weight management

US Market Access Strategy Consulting Patient interests alone are not reshaping the GLP-1 market

Understanding how the drug works, its benefits, and its side effects is important before starting treatment

Trends In FDA FY 2025 Warning Letters By Erin Hartmann and Liz Oestreich, ELIQUENT Life Sciences The U.S

Gif biology and fat metabolism

Meta-analyses suggest that GLP-1RAs can lead to an average BMI reduction of 12 kg/m 2 , a decrease in waist circumference of several centimeters, and total weight loss of 5%7% in some studies (85)